Track Choksi Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 10.66 %
Low
122.6
High
143.2
1 Month returns: 22.32 %
Low
106.4
High
143.2
1 Year returns: -37.92 %
Low
81.8
High
230.9
3 Year CAGR: 35.56 %
Low
38.3
High
236.7
5 Year CAGR: 51.56 %
Low
15.7
High
236.7
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Choksi Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Choksi Laboratories Ltd. Shareholding Pattern
Quarterly breakdown of Choksi Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Choksi Laboratories Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Choksi Laboratories Ltd.?
The current share price of Choksi Laboratories Ltd. is ₹ 137.00 as of 21 Aug 2026.
What is the market capitalisation of Choksi Laboratories Ltd.?
The market capitalisation of Choksi Laboratories Ltd. stands at ₹ 95.42 Cr.
What is the PE ratio of Choksi Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Choksi Laboratories Ltd. is 44.14 as of the latest trailing twelve months data.
What is the ROE and ROCE of Choksi Laboratories Ltd.?
Choksi Laboratories Ltd. has a Return on Equity (ROE) of 7.99% and a Return on Capital Employed (ROCE) of 8.97% as per the latest financial reports.
What is the 52-week high and low of Choksi Laboratories Ltd.?
The 52-week high of Choksi Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Choksi Laboratories Ltd.?
The dividend yield of Choksi Laboratories Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Choksi Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 7.02%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 51.62% of Choksi Laboratories Ltd. shares.
What sector does Choksi Laboratories Ltd. belong to?
Choksi Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Choksi Laboratories Ltd.?
The beta of Choksi Laboratories Ltd. is 0.48, indicating its price volatility relative to the broader market. Over the past 1 year, Choksi Laboratories Ltd. has delivered an absolute return of -36.76%.
What is the RSI of Choksi Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Choksi Laboratories Ltd. is 66.17, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Choksi Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 44.45% for 12-month ended 30 Jun 2026 and the growth was 22.97 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 44.14 indicates that the stock is expensive on a standalone basis and is at a 103.6% premium to industry median P/E
What is P/E Ratio?
Median: 21.68
Value 44.14
5.33378.26
Low but stable ROE
The company reported low ROE of 7.99% for 12-month ended 30 Jun 2026 and ROE improved marginally by 134 bps from 1 year ago
What is ROE (FY)?
Moderate revenue growth but lower than median growth of industry
The company delivered moderate revenue growth of 10.73% for 12-month ended 30 Jun 2026 but the growth was 3.84 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 14.57
Value 10.73
-93.87133.74
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Moderate and stable operating margin
The company reported moderate operating margin of 10.91% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -3 bps from 1 year ago
What is Operating profit margin?
Reasonable Debt to Equity, and has been stable
The company has reasonable Debt to Equity of 1.34 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.1 in the last 1 year
What is Debt to Equity?
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0650671.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
Indian Promoter
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
31.48
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
-
-
-
-
-
-
-
-
-
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.94
4.31
5.69
5.69
6.03
7.02
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.94
4.31
5.69
5.69
6.03
7.02
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
68.52
66.58
64.21
62.83
62.83
62.49
61.50
Bodies Corporate
3.11
3.09
3.08
2.96
2.18
3.98
3.97
4.18
4.10
4.18
4.74
4.52
4.55
4.54
4.64
5.08
4.58
4.38
4.02
4.37
10.61
12.50
12.16
11.91
10.89
9.88
Others (incl. Retail)
No. of shareholders
65.41
3,472
65.43
3,482
65.44
3,464
65.56
3,446
66.34
3,416
64.54
3,440
64.55
3,473
64.34
3,501
64.42
3,516
64.34
3,534
63.78
3,493
64.00
3,486
63.97
3,502
63.98
3,551
63.88
3,742
63.44
3,868
63.94
4,147
64.14
4,016
64.50
4,294
64.15
4,427
55.97
4,121
51.71
4,126
50.67
4,033
50.92
4,024
51.60
3,979
51.62
3,914
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Index Presence
Choksi Laboratories Ltd. is not part of any tracked index.
Overview of Choksi Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Choksi Laboratories Limited is an India-based provider of contract testing and analytical services. The Company analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environmental monitoring services. It operates through a single segment, which is analysis and testing. The Companys services include contract laboratory services, instrument calibration and validation services, environmental management services, clinical research, consultancy, and assaying and hallmarking (gold and silver). The Companys contract laboratory services include pharmaceutical analysis, food and beverages analysis, water analysis and construction material analysis. Its calibration services include laboratory and on-site calibration for test equipment, process equipment and, in many cases, end-user equipment; plant shutdown calibration, and consultancy for setting up an in-house calibration laboratory.
Choksi Laboratories Limited is an India-based provider of contract testing and analytical services. The Company analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environmental monitoring serv...
Key personnel
Mr. Prakhar Dubey
Compliance Officer, Company Secretary
Mr. Sunil Kumar ChoksiD
Executive Chairman of the Board, Managing Director